YiChang HEC ChangJiang Pharmaceutical Co., Ltd. engages in the development, manufacturing, and sale of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic, and cardiovascular diseases in the People's Republic of China. It manufactures and sells active pharmaceutical ingredients and drugs; researches and develops pharmaceutical products and medical devices, as well as biotechnology; and provides marketing and medical consulting services. The company's product portfolio includes Kewei, Oumeining, Xinhaining, Ertongshu, and Xining. It sells its products to hospitals and medical institutions through a network of distributors. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China.
Frequently asked questions
What sector does Yichang Hec Changjiang Pharm (1558) operate in?
Yichang Hec Changjiang Pharm belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Yichang Hec Changjiang Pharm (1558) current stock price?
As of the latest data, Yichang Hec Changjiang Pharm stock price is HK$15.88, with a previous close of HK$15.88.
What is Yichang Hec Changjiang Pharm (1558) current market capitalization?
Yichang Hec Changjiang Pharm market cap is approximately 10.38 billion.
What is Yichang Hec Changjiang Pharm (1558) Earnings Per Share (EPS)?
The trailing EPS is -HK$0.23, and the forward EPS is HK$1.86.
Does Yichang Hec Changjiang Pharm (1558) pay dividends?
No. Yichang Hec Changjiang Pharm does not pay a dividend.
What is Yichang Hec Changjiang Pharm (1558) beta (volatility) score?
Yichang Hec Changjiang Pharm has a beta of 0.073, indicating lower volatility than the overall market.
